Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.66	69.22	84.59	76.2	63.13	85.29
Short-Term Investments	41.36	31.75	11.35	4.87	18.98	8.1
Cash & Short-Term Investments	96.02	100.97	95.94	81.07	82.11	93.39
Cash Growth	-0.83%	5.24%	18.34%	-1.26%	-12.08%	-16.35%
Accounts Receivable	25.91	32.01	47.84	40.35	32.53	25.54
Other Receivables	-	-	-	1.92	-	-
Receivables	25.91	32.01	47.84	42.27	32.53	25.54
Inventory	8.59	8.72	7.08	4.53	7.11	3.45
Prepaid Expenses	1.87	1.83	2.48	2.62	8.98	11.26
Restricted Cash	2.09	-	-	-	8.85	8.85
Other Current Assets	2.1	4.13	2.85	3.79	0.45	3.64
Total Current Assets	136.58	147.66	156.19	134.28	140.02	146.14
Property, Plant & Equipment	3.22	5.09	8.65	12.51	15.77	18.89
Other Intangible Assets	46.26	51.13	60.87	70.61	66.13	74.14
Long-Term Deferred Tax Assets	7.08	7.08	-	-	-	-
Long-Term Deferred Charges	0.1	0.1	0.21	-	0.58	0.96
Other Long-Term Assets	1.68	2.27	4.62	4.66	4.09	4.1
Total Assets	194.92	213.33	230.53	222.06	226.59	244.22
Accounts Payable	5.42	5.51	6.89	6.44	11.17	12.08
Accrued Expenses	23.44	26.07	35.63	32.73	24.03	29.59
Current Portion of Long-Term Debt	34	45.33	34	-	-	14.29
Current Portion of Leases	4.36	5.54	4.8	4.14	3.57	3.09
Other Current Liabilities	11.88	13.66	18.07	34.17	70.81	55.21
Total Current Liabilities	79.1	96.11	99.38	77.48	109.59	114.26
Long-Term Debt	10.87	21.72	65.66	98.31	97.09	84.03
Long-Term Leases	-	1.49	7.03	11.83	15.98	19.55
Other Long-Term Liabilities	0.23	1.88	5.01	12.83	6.38	32.34
Total Liabilities	90.2	121.21	177.09	200.45	229.03	250.17
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,411	1,407	1,399	1,388	1,364	1,332
Retained Earnings	-1,306	-1,315	-1,345	-1,367	-1,367	-1,338
Comprehensive Income & Other	-0.01	0.01	-0	-	-0	-
Shareholders' Equity	104.72	92.13	53.44	21.61	-2.45	-5.95
Total Liabilities & Equity	194.92	213.33	230.53	222.06	226.59	244.22
Total Debt	49.23	74.08	111.49	114.28	116.64	120.95
Net Cash (Debt)	46.79	26.88	-15.55	-33.21	-34.54	-27.57
Net Cash Per Share	0.94	0.55	-0.33	-0.74	-0.85	-0.70
Filing Date Shares Outstanding	50.37	49.61	48.21	46.64	41.33	40.26
Total Common Shares Outstanding	49.89	49.11	47.65	46.35	41.18	40.09
Working Capital	57.48	51.55	56.8	56.8	30.44	31.88
Book Value Per Share	2.10	1.88	1.12	0.47	-0.06	-0.15
Tangible Book Value	58.46	40.99	-7.43	-49	-68.57	-80.09
Tangible Book Value Per Share	1.17	0.83	-0.16	-1.06	-1.67	-2.00
Machinery	4.69	4.6	4.76	4.79	4.84	4.85
Leasehold Improvements	3.78	3.78	3.78	3.78	3.78	3.78

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q